enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.96
-0.11 (-1.56%)
Mar 26, 2026, 4:00 PM EDT - Market closed
enGene Holdings Market Cap
enGene Holdings has a market cap or net worth of $466.25 million as of March 26, 2026. Its market cap has increased by 77.59% in one year.
Market Cap
466.25M
Enterprise Value
223.76M
1-Year Change
77.59%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $466.25M, an increase of 199.05%. That is a compound annual growth rate of 30.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 473.62M | -21.70% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 514.53M |
| CorMedix | 507.50M |
| Rigel Pharmaceuticals | 489.54M |
| Larimar Therapeutics | 486.17M |
| Prothena Corporation | 474.81M |
| Verastem | 473.43M |
| 4D Molecular Therapeutics | 471.21M |
| Rocket Pharmaceuticals | 471.19M |